- World Pharma News Home » Published News » Corporate
(a free service delivered by FeedBurner)
Boehringer Ingelheim signs a license agreement with Evec Inc. for its fully-human antibody programme
Boehringer Ingelheim has signed a licence agreement with Evec, Inc., Japan, for one of its fully-human therapeutic antibody programmes. Based on the agreement, Boehringer Ingelheim will obtain worldw
read more » 
Discuss Add this link to... Bury
Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that following the approval by shareholders at the Annual General Meeting on September 24, 2008, the
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Bayer Schering Pharma and the National University of Singapore (NUS) have agreed to cooperate in the field of pre-clinical cancer research. The initial collaboration with the NUS will focus on three
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
AstraZeneca today announced that the US District Court for the District of New Jersey has denied Teva's Motion for Summary Judgment of no infringement in the PULMICORT RESPULES (budesonide inhalatio
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Nycomed has announced a new strategy for its European manufacturing network. The company will focus its European production at five dedicated centres of competence and five facilities for regional su
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The life science industry increasingly demands for Europe-wide transport solutions which are able to guarantee product integrity. Being able to offer this, strengthens a global market position. Thus,
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Bayer Schering Pharma and the University of Nagasaki (Japan) have signed a licensing agreement on the use of novel substances for molecular imaging. Being used as tracers in Positron Emission Tomogra
read more »
1 Comment Add this link to... Bury
1 Comment Add this link to... Bury
The Abbott Fund joined representatives from the U.S. government, Baylor College of Medicine, the government of Tanzania and other partners today at a U.S. President's Emergency Plan for AIDS Relief
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GlaxoSmithKline (GSK) and Valeant Pharmaceuticals International (NYSE: VRX) announced that they have entered into an exclusive worldwide collaboration agreement for the investigational drug retigabin
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Genzyme Corp. (Nasdaq: GENZ), a global leader in biotechnology, and Medicines for Malaria Venture (MMV), a not-for-profit virtual research and development (R&D) organization dedicated to reducing the
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
